Buclizine dihydrochloride
- Level
- Commodity
- Parent
- 51313100
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51313109This classification denotes a histamine-1 receptor antagonist with the molecular formula C28H33ClN2.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 58FQD093NU, chemically known as piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((4-(1,1-dimethylethyl)phenyl)methyl)-, dihydrochloride, but more generally known as buclizine dihydrochloride, which bears US NIH Compound Identifier 6729. European Medicines Agency schedules buclizine dihydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05947MIG. Most nations, for tariff purposes, schedule buclizine dihydrochloride under HS 29335995. SMILES: CC(C)(C)C1CCC(CC1)CN2CCN(CC2)C(C3CCCCC3)C4CCC(CC4)CL.CL.CL.
Same parent
Under 51313100 · 20Activities that produce or sell this
KBLI · 9Inherited from family 51310000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.